KORU Medical Systems, Inc. (NASDAQ:KRMD) Receives Average Recommendation of “Moderate Buy” from Analysts

KORU Medical Systems, Inc. (NASDAQ:KRMD) has been assigned an average rating of “Moderate Buy” from the five brokerages that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $7.25.

Several analysts recently issued reports on KRMD shares. Wall Street Zen raised shares of KORU Medical Systems from a “hold” rating to a “buy” rating in a research note on Saturday, July 4th. Weiss Ratings lowered shares of KORU Medical Systems from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, July 15th.

Insider Activity at KORU Medical Systems

In related news, insider Adam R. Kalbermatten acquired 12,500 shares of KORU Medical Systems stock in a transaction that occurred on Thursday, June 11th. The shares were purchased at an average price of $3.94 per share, for a total transaction of $49,250.00. Following the completion of the transaction, the insider owned 312,500 shares in the company, valued at $1,231,250. This represents a 4.17% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders purchased a total of 28,000 shares of company stock valued at $109,430 over the last ninety days. 18.50% of the stock is currently owned by company insiders.

Institutional Trading of KORU Medical Systems

Large investors have recently added to or reduced their stakes in the stock. Cubist Systematic Strategies LLC raised its holdings in shares of KORU Medical Systems by 927.4% during the 1st quarter. Cubist Systematic Strategies LLC now owns 77,280 shares of the company’s stock worth $196,000 after acquiring an additional 69,758 shares during the period. Goldman Sachs Group Inc. grew its holdings in shares of KORU Medical Systems by 189.5% in the first quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock valued at $617,000 after purchasing an additional 158,914 shares during the period. Jane Street Group LLC grew its holdings in shares of KORU Medical Systems by 136.7% in the first quarter. Jane Street Group LLC now owns 163,137 shares of the company’s stock valued at $414,000 after purchasing an additional 94,214 shares during the period. Acadian Asset Management LLC acquired a new stake in KORU Medical Systems during the first quarter worth about $63,000. Finally, Geode Capital Management LLC increased its position in KORU Medical Systems by 101.3% during the second quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock worth $3,571,000 after purchasing an additional 501,875 shares during the last quarter. 58.60% of the stock is currently owned by hedge funds and other institutional investors.

KORU Medical Systems Stock Performance

Shares of NASDAQ KRMD traded up $0.04 during mid-day trading on Thursday, reaching $4.11. The company’s stock had a trading volume of 5,741 shares, compared to its average volume of 160,877. The stock has a 50-day moving average of $4.12 and a two-hundred day moving average of $4.44. The stock has a market capitalization of $188.54 million, a P/E ratio of -82.10 and a beta of 0.41. KORU Medical Systems has a 1-year low of $3.20 and a 1-year high of $6.61.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.